You are currently viewing a new version of our website. To view the old version click .

Assessing, Understanding and Mitigating the Impact of COVID-19 on TB Prevention, Care and Control

This special issue belongs to the section “Infectious Diseases“.

Special Issue Information

Dear Colleagues,

The COVID-19 pandemic has created many barriers to tuberculosis (TB) treatment and care, and it is threatening progress on reducing the global burden of this disease. In fact, 12 months of COVID-19 has eliminated 12 years of progress in fighting TB, according to the Stop TB Partnership.

Given the potential diversion of resources, shortages of staff, disruption of services, among other factors, new or adapted strategies are required to mitigate the potential impact of COVID on TB control efforts, ensure continuity of TB services and activities, and protect the lives of people with TB during this pandemic.

In this Special issue, we are calling for articles (perspectives, original articles and reviews) that document the impact of COVID-19 on TB patients and/or the TB continuum of care, as well as the testing, evaluation, implementation or scaling up of new interventions and approaches that will help understand and mitigate the impact of the COVID-19 pandemic across the TB prevention, care and control cascade.

We seek submissions from around the world, but we are particularly encouraging submissions from individuals working in TB high-burden countries.

Dr. Debora Pedrazzoli
Dr. Palwasha Khan
Dr. Corinne Merle
Dr. Vanessa Veronese
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Tropical Medicine and Infectious Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Tuberculosis
  • COVID-19
  • Impact assessment
  • Evaluation

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Trop. Med. Infect. Dis. - ISSN 2414-6366